Kanvic Consulting’s Post

India's private equity (PE) and venture capital (VC) investments are projected to hit $5.33 billion across 57 deals in 2024 Private equity (PE) and venture capital (VC) investments in India’s healthcare sector are projected to hit $5.33 billion across 57 deals in 2024. The healthcare investments remain consistent with post-pandemic annual levels of $5-6 billion, a stark rise from pre-Covid figures of $3-4 billion. The sector’s growth trajectory is cyclical. Investors are in the early stages of their commitments, focusing on scaling assets before exits trigger fresh investment cycles. Sub-segments like healthcare delivery and pharmaceuticals dominate, overtaking health tech, which surged during the pandemic. Favourable macro factors such as rising middle-class households and growing health insurance penetration—from 25% in 2013 to 65% in 2023—continue to fuel sector resilience. India’s healthcare and life sciences market is forecasted to grow to $285 billion by 2028, doubling the pace of GDP growth. While 35% of the population remains uninsured, improved insurance coverage presents untapped opportunities. Experts predict a steady investment flow, maintaining the sector’s “new normal” of $5-6 billion annually, driven by rising healthcare demands and favourable demographics. PE-VC funds will focus on scaling existing investments, with a potential upswing in deals post-2025 as assets mature and exits are triggered. #Equity #Capital #healthcaresector #investments #investmentstrategy

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics